P3 Health Partners Inc. (PIIIW)
USD 0.01
(10.2%)
USD 0.01
(10.2%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 83.7 Million USD | -5.31% |
| 2022 | 88.4 Million USD | 274.86% |
| 2021 | -50.55 Million USD | -493.39% |
| 2020 | 12.85 Million USD | 211.2% |
| 2019 | -11.55 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 67.94 Million USD | -27.09% |
| 2024 Q1 | 100.2 Million USD | 19.71% |
| 2023 Q2 | 60.06 Million USD | -47.21% |
| 2023 FY | 83.7 Million USD | -5.31% |
| 2023 Q4 | 83.7 Million USD | 20.88% |
| 2023 Q3 | 69.24 Million USD | 15.29% |
| 2023 Q1 | 113.76 Million USD | 28.69% |
| 2022 Q1 | -21.6 Million USD | 57.27% |
| 2022 Q4 | 88.4 Million USD | 55.63% |
| 2022 FY | 88.4 Million USD | 274.86% |
| 2022 Q3 | 56.79 Million USD | 98.54% |
| 2022 Q2 | 28.6 Million USD | 232.44% |
| 2021 FY | -50.55 Million USD | -493.39% |
| 2021 Q4 | -50.55 Million USD | -182.12% |
| 2021 Q3 | 61.56 Million USD | 33.28% |
| 2021 Q1 | 63.62 Million USD | 395.1% |
| 2021 Q2 | 46.19 Million USD | -27.4% |
| 2020 Q4 | 12.85 Million USD | 0.0% |
| 2020 Q1 | 32.59 Million USD | 0.0% |
| 2020 FY | 12.85 Million USD | 211.2% |
| 2019 FY | -11.55 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 94.066% |
| Addus HomeCare Corporation | 110.39 Million USD | 24.172% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 6.374% |
| Amedisys, Inc. | 341.35 Million USD | 75.478% |
| American Oncology Network, Inc. | 99.78 Million USD | 16.113% |
| Astrana Health, Inc. | 27.2 Million USD | -207.667% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 94.248% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 37889.094% |
| biote Corp. | 25.86 Million USD | -223.58% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -697.972% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 807.762% |
| COMPASS Pathways plc | -187.58 Million USD | 144.623% |
| DocGo Inc. | -12.78 Million USD | 754.523% |
| The Ensign Group, Inc. | 1.36 Billion USD | 93.853% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 882.674% |
| InnovAge Holding Corp. | 56.08 Million USD | -49.24% |
| Assure Holdings Corp. | 14.68 Million USD | -470.133% |
| The Joint Corp. | -2.47 Million USD | 3476.017% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 80.633% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 1483.458% |
| ModivCare Inc. | 1.13 Billion USD | 92.64% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -29961.878% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -1964.125% |
| Option Care Health, Inc. | 822.56 Million USD | 89.824% |
| P3 Health Partners Inc. | 83.7 Million USD | 0.0% |
| The Pennant Group, Inc. | 323.57 Million USD | 74.13% |
| Surgery Partners, Inc. | 2.86 Billion USD | 97.079% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 2860.81% |
| Talkspace, Inc. | -123.9 Million USD | 167.556% |
| Talkspace, Inc. | -123.9 Million USD | 167.556% |
| The Oncology Institute, Inc. | 86.32 Million USD | 3.035% |
| The Oncology Institute, Inc. | 86.32 Million USD | 3.035% |